KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Construction in Progress: 2010-2013

Historic Construction in Progress for Biomarin Pharmaceutical (BMRN) over the last 4 years, with Dec 2013 value amounting to $77.2 million.

  • Biomarin Pharmaceutical's Construction in Progress rose 20.08% to $77.2 million in Q4 2013 from the same period last year, while for Dec 2013 it was $77.2 million, marking a year-over-year increase of 20.08%. This contributed to the annual value of $77.2 million for FY2013, which is 20.08% up from last year.
  • Biomarin Pharmaceutical's Construction in Progress amounted to $77.2 million in FY2013, which was up 20.08% from $64.3 million recorded in FY2012.
  • In the past 5 years, Biomarin Pharmaceutical's Construction in Progress ranged from a high of $77.2 million in FY2013 and a low of $14.7 million during FY2010.
  • Its 3-year average for Construction in Progress is $65.1 million, with a median of $64.3 million in 2012.
  • Data for Biomarin Pharmaceutical's Construction in Progress shows a peak YoY spiked of 265.84% (in 2011) over the last 5 years.
  • Yearly analysis of 4 years shows Biomarin Pharmaceutical's Construction in Progress stood at $14.7 million in 2010, then soared by 265.84% to $53.9 million in 2011, then climbed by 19.33% to $64.3 million in 2012, then grew by 20.08% to $77.2 million in 2013.